Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
121
121 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CagrilintidePhase 320 trials
Novo Nordisk · Obesity, Overweight, Type 2 Diabetes
- HRS-7535Phase 310 trials
Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity
- INS1009Treprostinil PalmitilPhase 37 trials
Insmed Incorporated · Interstitial Lung Disease, Pulmonary Hypertension, Pulmonary Arterial Hypertension
- CagriSemaCagrilintide B and Semaglutide IPhase 36 trials
Novo Nordisk · Obesity, Diabetes Mellitus, Type 2, Hypertension
- Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials
United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
- lorundrostatPhase 35 trials
Mineralys Therapeutics Inc. · Hypertension, Obstructive Sleep Apnea, Chronic Kidney Disease
- VCT220CX11Phase 35 trials
Vincentage Pharma Co., Ltd · Obesity, Type 2 Diabetes Mellitus (DM), Hypertension
- VicadrostatBI 690517Phase 35 trials
Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension
- ZilebesiranALN-AGT01Phase 34 trials
Alnylam Pharmaceuticals · Hypertension, High Cardiovascular Risk, High Risk Cardiovascular Disease
- Bimatoprost Implant SystemPhase 33 trials
SpyGlass Pharma, Inc. · Cataract, Glaucoma, Ocular Hypertension
- HRS-1780Phase 33 trials
Shandong Suncadia Medicine Co., Ltd. · Chronic Kidney Disease, Uncontrolled or Resistant Hypertension, Primary Aldosteronism
- Timolol eye drops 0.5%Phase 33 trials
Glaukos Corporation · Glaucoma, Ocular Hypertension
- TNX-103Phase 33 trials
Tenax Therapeutics, Inc. · Pulmonary Hypertension Associated With HFpEF, Pulmonary Hypertension
- ClazakizumabLY5724886, CSL300Phase 32 trials
Eli Lilly · Atherosclerosis, Cardiovascular Disease, Obesity
- DWC202314Phase 32 trials
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension, Hypertension
- DWC202314PPhase 32 trials
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension, Hypertension
- Experimental: SacubitrilPhase 32 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Essential Hypertension
- HCP1803-3Phase 32 trials
Hanmi Pharmaceutical Company Limited · Hypertension
- IKT-001Phase 32 trials
Inhibikase Therapeutics · Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH)
- Inactive controlQLS-111 vehiclePhase 32 trials
Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)
- MosliciguatPhase 32 trials
Pulmovant, Inc. · Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases
- NCX 470NCX 470 0.1%Phase 32 trials
Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension
- RalinepagAPD811Phase 32 trials
United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension
- RLD2001-1Phase 32 trials
Hanmi Pharmaceutical Company Limited · Hypertension
- SAL0120Phase 32 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Chronic Kidney Disease, Uncontrolled Hypertension, Resistant Hypertension
- SeralutinibPhase 32 trials
Gossamer Bio USA, Inc. · Pulmonary Arterial Hypertension
- AD-223APhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-223BPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-223CPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-224APhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-224BPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-224CPhase 31 trial
Addpharma Inc. · Hypertension,Essential
- AD-227APhase 31 trial
Addpharma Inc. · Essential Hypertension
- AD-227BPhase 31 trial
Addpharma Inc. · Essential Hypertension
- AD-227CPhase 31 trial
Addpharma Inc. · Essential Hypertension
- ATB-1011Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1012Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- ATB-1013Phase 31 trial
Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2
- BR1018APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1018C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia
- BR1019APhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019A-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019BPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019B-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019CPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
- BR1019C-1Phase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.